Wells Fargo & Company Issues Pessimistic Forecast for iTeos ...

Dec 21, 2024  · Shares of iTeos Therapeutics stock opened at $7.42 on Thursday. iTeos Therapeutics has a 52-week low of $7.09 and a 52-week high of $18.75. The company has a …


$7.42
OFF

Wells Fargo & Company Issues Pessimistic Forecast For ITeos ...

1 day from now

Dec 21, 2024  · Shares of iTeos Therapeutics stock opened at $7.42 on Thursday. iTeos Therapeutics has a 52-week low of $7.09 and a 52-week high of $18.75. The company has a …

etfdailynews.com

$31.00
OFF

Wells Fargo & Company Has Lowered Expectations For ITeos …

1 day from now

Dec 21, 2024  · iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its price target cut by analysts at Wells Fargo & Company from $31.00 to $19.00 in a report released on …

defenseworld.net

$19.00
OFF

ITeos Therapeutics (NASDAQ:ITOS) Price Target Lowered To $19.00 …

1 day from now

Dec 19, 2024  · Wells Fargo & Company cut their price objective on shares of iTeos Therapeutics from $31.00 to $19.00 and set an "overweight" rating for the company in a research report on …

marketbeat.com

$19
OFF

ITeos Therapeutics Price Target Lowered To $19 From $31 At Wells …

1 day from now

Dec 19, 2024  · Wells Fargo lowered the firm’s price target on iTeos Therapeutics to $19 from $31 and keeps an Overweight rating on the shares.The firm adjusted price targets in the Smid-cap …

businessinsider.com

$19.00
OFF

ITeos Therapeutics (NASDAQ:ITOS) Given New $19.00 Price Target …

1 day from now

Dec 19, 2024  · iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its price target decreased by equities researchers at Wells Fargo & Company from $31.00 to $19.00 in a …

techdows.com

$31
OFF

Wells Fargo Maintains Overweight On ITeos Therapeutics, Lowers …

1 day from now

Dec 19, 2024  · Wells Fargo analyst Eva Fortea Verdejo maintains ITeos Therapeutics (NASDAQ:ITOS) with a Overweight and lowers the price target from $31 to $19.

sahmcapital.com

79%
OFF

Wells Fargo Initiates Coverage Of ITeos Therapeutics (ITOS

1 day from now

Aug 6, 2024  · Analyst Price Forecast Suggests 163.79% Upside As of August 6, 2024, the average one-year price target for iTeos Therapeutics is $38.25/share. The forecasts range …

nasdaq.com

$85.00
OFF

Wells Fargo & Company Issues Pessimistic Forecast For Lam …

1 day from now

Dec 7, 2024  · Lam Research (NASDAQ:LRCX - Free Report) had its price objective trimmed by Wells Fargo & Company from $85.00 to $83.00 in a research note released on Friday …

marketbeat.com

$47.00
OFF

Wells Fargo & Company Issues Pessimistic Forecast For …

1 day from now

Dec 21, 2024  · Immunovant (NASDAQ:IMVT – Get Free Report) had its target price lowered by stock analysts at Wells Fargo & Company from $47.00 to $45.00 in a research report issued to …

defenseworld.net

$70.00
OFF

Wells Fargo & Company Issues Pessimistic Forecast For General …

1 day from now

Dec 21, 2024  · General Mills (NYSE:GIS – Get Free Report) had its target price lowered by research analysts at Wells Fargo & Company from $70.00 to $68.00 in a research report …

defenseworld.net

$45.00
OFF

Wells Fargo & Company Issues Pessimistic Forecast For Essential ...

1 day from now

Nov 5, 2024  · Essential Utilities (NYSE:WTRG - Free Report) had its price objective decreased by Wells Fargo & Company from $45.00 to $43.00 in a research report report published on …

marketbeat.com

$13.64
OFF

Wells Fargo & Company Has Lowered Expectations For Aptiv

1 day from now

Dec 16, 2024  · The company has a market capitalization of $13.64 billion, a price-to-earnings ratio of 6.47, a P/E/G ratio of 0.59 and a beta of 1.78. Aptiv has a 52-week low of $51.47 and a …

marketbeat.com

$300.00
OFF

Wells Fargo & Company Issues Pessimistic Forecast For

1 day from now

Nov 26, 2024  · Wells Fargo & Company lowered their target price on shares of Constellation Brands from $300.00 to $295.00 and set an "overweight" rating on the stock in a report on …

marketbeat.com

$26.27
OFF

Wells Fargo & Company Issues Pessimistic Forecast For

1 day from now

Dec 19, 2024  · The company has a debt-to-equity ratio of 0.93, a current ratio of 0.37 and a quick ratio of 0.37. The stock's 50-day moving average is $26.27 and its two-hundred day moving …

marketbeat.com


Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension